GHTC issues statement on R&D for epidemic diseases at WHO Executive Board meeting
GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board, welcoming efforts by WHO to advance frameworks to catalyze development of new technologies to combat potentially epidemic diseases and support regulatory models and procurement systems to accelerate the pace at which these tools reach patients. The statement was issued in partnership with the Global Health Council and PATH.